Literature DB >> 8263201

Ehrlichia chaffeensis and Rochalimaea antibodies in Kawasaki disease.

M H Rathore1, L L Barton, J E Dawson, R L Regnery, E M Ayoub.   

Abstract

Sera from 38 patients with Kawasaki disease were tested for immunofluorescent antibodies to Ehrlichia chaffeensis, Rochalimaea henselae, and R. quintana Oklahoma. Only 2.5% of the patients tested positive for E. chaffeensis, and 5% were positive for R. henselae and R. quintana Oklahoma. Our data suggest that Ehrlichia and Rochalimaea spp. do not play a unique role in the etiology of Kawasaki disease.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8263201      PMCID： PMC266216          DOI： 10.1128/jcm.31.11.3058-3059.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

Review 1.  Infections due to Rochalimaea: the expanding clinical spectrum.

Authors:  W A Schwartzman
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

2.  Human herpesvirus 6 infection and Kawasaki disease.

Authors:  M Okano; J Luka; G M Thiele; Y Sakiyama; S Matsumoto; D T Purtilo
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

3.  Spirochaetal studies in Kawasaki syndrome.

Authors:  N J Marchette; M E Melish; J F James; S Kihara; F Caplan
Journal:  Prog Clin Biol Res       Date:  1987

4.  Rickettsia-like bodies in infantile acute febrile mucocutaneous lymph-node syndrome.

Authors:  Y Hamashima; K Kishi; K Tasaka
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

5.  Positive Ehrlichia canis serology in Kawasaki disease.

Authors:  E A Edlinger; J Benichou; B Labrune
Journal:  Lancet       Date:  1980-05-24       Impact factor: 79.321

Review 6.  Kawasaki syndrome: review of new epidemiologic and laboratory developments.

Authors:  A M Rauch
Journal:  Pediatr Infect Dis J       Date:  1987-11       Impact factor: 2.129

7.  Epstein-Barr virus and other herpesvirus infections in Kawasaki syndrome.

Authors:  N J Marchette; M E Melish; R Hicks; S Kihara; E Sam; D Ching
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

8.  Rochalimaea henselae sp. nov., a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis.

Authors:  D F Welch; D A Pickett; L N Slater; A G Steigerwalt; D J Brenner
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

9.  Characterization of a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient.

Authors:  R L Regnery; B E Anderson; J E Clarridge; M C Rodriguez-Barradas; D C Jones; J H Carr
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

10.  Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis.

Authors:  J E Dawson; B E Anderson; D B Fishbein; J L Sanchez; C S Goldsmith; K H Wilson; C W Duntley
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948
View more
  4 in total

1.  Serologic diagnosis of human monocytic ehrlichiosis by immunoblot analysis.

Authors:  P Brouqui; C Lecam; J Olson; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

Review 2.  Kawasaki disease: what is the epidemiology telling us about the etiology?

Authors:  David Burgner; Anthony Harnden
Journal:  Int J Infect Dis       Date:  2005-07       Impact factor: 3.623

Review 3.  Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota.

Authors:  Kazunari Kaneko; Shohei Akagawa; Yuko Akagawa; Takahisa Kimata; Shoji Tsuji
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

Review 4.  Infection and vasculitis.

Authors:  Cristina C Belizna; Mohamed A Hamidou; Hervé Levesque; Loic Guillevin; Yehuda Shoenfeld
Journal:  Rheumatology (Oxford)       Date:  2009-03-03       Impact factor: 7.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.